Evidence map›Paper›PMID 33169370›Full record

ArticleClinical genetics2021

A BBS1 SVA F retrotransposon insertion is a frequent cause of Bardet-Biedl syndrome.

Clarisse Delvallée, Samuel Nicaise, Manuela Antin, Anne-Sophie Leuvrey, Elsa Nourisson, Carmen C Leitch, Georgios Kellaris, Corinne Stoetzel, Véronique Geoffroy, Sophie Scheidecker and 17 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. WGS Revealed NovelInternational journal of molecular sciences · 2023
    Article
  7. Review
  8. Article
  9. Mechanisms of disease-associated SINE-VNTR-Alus.Experimental biology and medicine (Maywood, N.J.) · 2022
    Review
  10. Review
  11. Characterisation of the Function of a SINE-VNTR-Frontiers in molecular neuroscience · 2022
    Article
  12. Article
  13. Clinical and genetic heterogeneity of primary ciliopathies (Review).International journal of molecular medicine · 2021
    Review
  14. Article
  15. Next-Generation Sequencing Applications for Inherited Retinal Diseases.International journal of molecular sciences · 2021
    Review
  16. Article
  17. Long-Read Sequencing to Unravel Complex Structural Variants ofFrontiers in cell and developmental biology · 2021
    Article
  18. Article
  19. Exploring the Spectrum of Kidney Ciliopathies.Diagnostics (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 11 institutions in 5 countries.

Clarisse DelvalléeLaboratoire de Génétique Médicale, Institut de génétique médicale d'Alsace IGMA, INSERM U1112, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg UMRS_1112, Strasbourg, France.
Samuel NicaiseLaboratoire de Génétique Médicale, Institut de génétique médicale d'Alsace IGMA, INSERM U1112, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg UMRS_1112, Strasbourg, France.
Manuela AntinLaboratoires de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Anne-Sophie LeuvreyLaboratoires de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Elsa NourissonLaboratoires de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Carmen C LeitchAdvanced Center for Translational and Genetic Medicine (ACT-GeM), Stanley Manne Children's Research Institute, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Georgios KellarisAdvanced Center for Translational and Genetic Medicine (ACT-GeM), Stanley Manne Children's Research Institute, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Corinne StoetzelLaboratoire de Génétique Médicale, Institut de génétique médicale d'Alsace IGMA, INSERM U1112, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg UMRS_1112, Strasbourg, France.
Véronique GeoffroyLaboratoire de Génétique Médicale, Institut de génétique médicale d'Alsace IGMA, INSERM U1112, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg UMRS_1112, Strasbourg, France.
Sophie ScheideckerLaboratoire de Génétique Médicale, Institut de génétique médicale d'Alsace IGMA, INSERM U1112, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg UMRS_1112, Strasbourg, France.
Boris KerenInstitut du Cerveau et de la Moelle épinière (ICM), Sorbonne Université, Paris, France.
Christel DepienneInstitut du Cerveau et de la Moelle épinière (ICM), Sorbonne Université, Paris, France.
Joakim KlarDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.ORCID 0000-0003-4185-7409
Niklas DahlDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Jean-François DeleuzeCentre National de Recherche en Génomique Humaine (CNRGH), Institut de biologie François Jacob, Evry, France.
Emmanuelle GéninInserm UMR1078, CHRU Brest, Univ Brest, Brest, France.
Richard RedonUniversité de Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
Florence DemurgerService de Génétique Médicale, Centre Hospitalier Bretagne Atlantique, Vannes, France.
Koenraad DevriendtCenter for Human Genetics, University Hospital Leuven and KU Leuven, Leuven, Belgium.
Michèle Mathieu-DramardCentre d'activité de génétique clinique, CLAD nord de France, CHU Amiens, Amiens, France.
Christine Poitou-BernertAssistance Publique Hôpitaux de Paris, Nutrition Department Pitié-Salpêtrière Hospital; Sorbonne Université, INSERM, NutriOmics Research Unit, Paris, France.
Sylvie OdentCentre de Référence Maladies Rares CLAD-Ouest, Service de Génétique Clinique, CHU Rennes, Rennes, France.
Nicholas KatsanisAdvanced Center for Translational and Genetic Medicine (ACT-GeM), Stanley Manne Children's Research Institute, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Jean-Louis MandelLaboratoires de Diagnostic Génétique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Erica E DavisAdvanced Center for Translational and Genetic Medicine (ACT-GeM), Stanley Manne Children's Research Institute, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Hélène DollfusLaboratoire de Génétique Médicale, Institut de génétique médicale d'Alsace IGMA, INSERM U1112, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg UMRS_1112, Strasbourg, France.
Jean MullerLaboratoire de Génétique Médicale, Institut de génétique médicale d'Alsace IGMA, INSERM U1112, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg UMRS_1112, Strasbourg, France.ORCID 0000-0002-7682-559X
Inserm · FRCentre National de la Recherche Scientifique · FRHôpitaux Universitaires de Strasbourg · FRLurie Children's Hospital · USNorthwestern University · USSorbonne Université · FRUppsala University · SECenter for Human Genetics · USCentre hospitalier Bretagne Atlantique · FRCentre Hospitalier Universitaire Amiens-Picardie · FRCentre National de Recherche en Génomique Humaine · FR

Funding

Molecular Genetics of BBSR01HD042601 · NICHD · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI DAVIS, ERICA ELLEN · 2003 to 2023
$8.2M
Genetic and Functional Studies of Human Ciliary SyndromesR01DK072301 · NIDDK · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI DAVIS, ERICA ELLEN · 2005 to 2022
$7.2M
The Role of Basal Bodies in Wnt SignalingR01GM121317 · NIGMS · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI DAVIS, ERICA ELLEN · 2016 to 2019
$1.7M
NICHD NIH HHS R01 HD042601NIDDK NIH HHS R01 DK072301NIGMS NIH HHS R01 GM121317
6 · The paper itself

Abstract

Bardet-Biedl syndrome (BBS) is a ciliopathy characterized by retinitis pigmentosa, obesity, polydactyly, cognitive impairment and renal failure. Pathogenic variants in 24 genes account for the molecular basis of >80% of cases. Toward saturated discovery of the mutational basis of the disorder, we carefully explored our cohorts and identified a hominid-specific SINE-R/VNTR/Alu type F (SVA-F) insertion in exon 13 of BBS1 in eight families. In six families, the repeat insertion was found in trans with c.1169 T > G, p.Met390Arg and in two families the insertion was found in addition to other recessive BBS loci. Whole genome sequencing, de novo assembly and SNP array analysis were performed to characterize the genomic event. This insertion is extremely rare in the general population (found in 8 alleles of 8 BBS cases but not in >10 800 control individuals from gnomAD-SV) and due to a founder effect. Its 2435 bp sequence contains hallmarks of LINE1 mediated retrotransposition. Functional studies with patient-derived cell lines confirmed that the BBS1 SVA-F is deleterious as evidenced by a significant depletion of both mRNA and protein levels. Such findings highlight the importance of dedicated bioinformatics pipelines to identify all types of variation.

Indexed as

RetroelementsBardet-Biedl SyndromeCohort StudiesFemaleFounder EffectGene FrequencyHumansMaleMicrotubule-Associated ProteinsMutagenesis, InsertionalPedigreeWhole Genome SequencingBbs1 protein, humanMicrotubule-Associated ProteinsRetroelementsBardet-Biedl syndromeBBS1founder effectMobile element insertionSVA F

Identifiers

PMID33169370
PMCPMC8253169
OpenAlexW3101256958

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.